01927nas a2200229 4500008004100000245006800041210006600109260001500175300001000190490000700200520124700207653002601454653001401480653001301494653001401507653001701521100002501538700002701563700001901590700002901609856005901638 2021 eng d00aPhysician’s Practice of Adverse Drug Reaction in Saudi Arabia0 aPhysician s Practice of Adverse Drug Reaction in Saudi Arabia cMarch 2021 a13-190 v103 a

Objectives: To discover the healthcare providers (physicians and dentists) practice of the adverse drug reaction reporting system in Saudi Arabia. Methods: It was a crosssectional study with a self-administered electronic authenticated survey distributed to Saudi Arabia physicians and dentists. The survey contained of demographic data and rudiments of practicing the ADR reporting system, the number of ADR reported, the method of ADR reporting systems. Results: The total number of participants was 151. Of those, 111 (73.5%) were physicians, while dentists were 39 (26.5%). Of those 52 (35.68%), only those who reported the ADR despite most responders 138 (92.62%) thought the ADR reporting system was critical. The average scores of physicians practice ADR elements were 2.59. The physicians and dentists’ responders had a high score of the agreement; ADR’s essential tasks as a pharmacist. Conclusion: Over the past twenty years, more than theory studies and our study specified that ADR physicians’ reporting was terrible. The switching accountability of ADR reporting from healthcare providers to the pharmacist is highly suggested.

10aAdverse drug reaction10aPhysician10aPractice10aReporting10aSaudi Arabia1 aAlomi, Yousef, Ahmed1 aAlamoudi, Nouf, Hassan1 aAlanazi, Sabah1 aAlmasoudi, Abeer, Hussin uhttps://ijphs.org/article/2021/10/1/105530ijpcs2021103